| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 07/05/2006 | CN1798757A Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/22/2006 | WO2006003013A3 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 06/14/2006 | EP1669073A2 Fulvestrant formulation |
| 06/01/2006 | US20060116359 17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters |
| 05/30/2006 | US7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/10/2006 | CN1255425C Process and intermediates for production of 7-substituted antiestrogens |
| 05/04/2006 | WO2006015081A3 A PROCESS FOR THE PREPARATION OF 7α-ALKYLATED 19-NORSTEROIDS |
| 05/02/2006 | US7038040 Process for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 04/26/2006 | EP1648232A2 Method of treating hit patients with argatroban |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/22/2006 | CN1751061A Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751060A Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 03/15/2006 | EP1633367A2 Antiangiogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/02/2006 | WO2006021776A1 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 03/02/2006 | CA2576922A1 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 03/01/2006 | EP1630167A1 Polymorphs of 19-Nor steroid derivatives |
| 02/23/2006 | US20060041151 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 02/09/2006 | US20060030551 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 02/09/2006 | CA2574967A1 A process for the preparation of 7.alpha.-alkylated 19-norsteroids |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 01/31/2006 | US6993229 Method of making spun optical fiber with low PMD |
| 01/31/2006 | US6992075 dehydrogenating estrogenic salts by heating in high humidity to produce conjugated estrogen salts; 14-hydroxy (or hydroperoxy)- Delta 8,9-Dehydroestrone Sodium Sulfate; side effect reduction; hormone replacement therapy |
| 01/25/2006 | EP1618121A1 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate |
| 01/19/2006 | US20060014727 Angiogenic compounds and uses thereof |
| 01/12/2006 | WO2006003013A2 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 01/05/2006 | US20060002861 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 01/04/2006 | EP1611149A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 01/03/2006 | US6982329 provides synthetic methodology that may be employed to prepare steroid compounds having specified chemical functionality; steroids containing cyclohexene moiety are oxidized to corresponding alpha , beta -unsaturated ketone |
| 12/21/2005 | EP1144431B1 16-hydroxyestratrienes as selective estrogens |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/15/2005 | WO2005030120A3 Antiangiogenic agents |
| 11/17/2005 | US20050256325 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 11/17/2005 | US20050256094 especially those of the 20-spiroxane series; 11,12-epoxy steroid, 4,5-9,11-diepoxy steroid and 12-keto intermediates; Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-,?-lactone, methyl ester, (7a,11a,17a)-; eplerenone or epoxymexrenone; minimum of isolation steps |
| 11/16/2005 | EP1594886A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 11/16/2005 | EP1594884A1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 11/16/2005 | CN1227011C Method of treating adenosine depletion |
| 11/10/2005 | WO2005105823A1 Steroid derivatives |
| 11/02/2005 | CN1690073A Steroid derivatives |
| 10/27/2005 | US20050239761 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/19/2005 | EP1586579A1 Process for the preparation of delta(15-16)-17-ketosteroids and use thereof in the synthesis of pharmacologically active compounds |
| 10/19/2005 | EP1250138B1 Fulvestrant formulation |
| 10/12/2005 | CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 10/12/2005 | CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent |
| 10/12/2005 | CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/12/2005 | CN1222292C Fulvestrant formulation |
| 10/11/2005 | US6953851 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/06/2005 | US20050222107 Novel process |
| 10/06/2005 | US20050222098 Regulation of meiosis |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/22/2005 | US20050209477 Process for producing vinyl perfluoroalkanesulfonate derivative |
| 09/21/2005 | EP1575983A1 17.beta-[alpha-hydroxy]-esters of androstanes as intermediates for the preparation of 17.beta.-fluorinated-androstane esters |
| 09/21/2005 | EP1575981A1 Angiogenic compounds and uses thereof |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/07/2005 | EP1569951A2 Novel crystalline complexes |
| 09/01/2005 | US20050192437 Process for the preparation of 6alpha-fluoro steroids by isomerisation of 6beta-fluorosteroids |
| 08/25/2005 | WO2005077968A2 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/25/2005 | US20050187202 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols |
| 08/25/2005 | DE19540233B4 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 08/25/2005 | CA2552843A1 Steroids for cancer treatment |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/23/2005 | US6933383 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/04/2005 | US20050171074 3 alpha-hydroxy-3 beta-methoxymethyl-substituted steroids and the use thereof |
| 07/28/2005 | US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder |
| 07/21/2005 | US20050159594 Aldosterone receptor antagonist; comprises 7-methyl hydrogen 4a,5a;9a,11a-diepoxy-17 hydroxy-3-oxo-17a-pregnane-7a,21-dicarboxylate, gamma-lactone as dopant |
| 07/20/2005 | EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma |
| 07/20/2005 | EP1553954A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/20/2005 | CN1642969A Process for the production of fluticasone propionate, in particular of polymorphic form 1 |
| 07/14/2005 | WO2004024745A3 Complexes of 6.alpha. 9.alpha. - difluoro - 17. alpha. - [ (2 - furanylcarbonyl) oxy] - 11.beta. -hydroxy - 16- .alpha. -methyl - 3oxo- androsta- 1,4 -diene - 17 .beta. -carbothioic acid s-fluoromethyl ester |
| 07/14/2005 | US20050152845 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |
| 07/13/2005 | EP1553082A1 Process for production of vinyl perfluoroalkanesulfonate derivatives |
| 06/30/2005 | US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 06/23/2005 | WO2005042422A3 Optical fiber with low pmd and method of making it by spinning |
| 06/21/2005 | CA2213339C Method of treating adenosine depletion |
| 06/16/2005 | WO2005054271A1 Assay for ligands of the ecdysone receptor |
| 06/16/2005 | CA2547609A1 Assay for ligands of the ecdysone receptor |
| 06/15/2005 | EP1539796A1 Anti-inflammatory or anti-allergic androstane complexes |
| 06/15/2005 | CN1628125A Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid |
| 06/01/2005 | EP1534733A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 05/31/2005 | US6900193 Urogential disorders; antitumor agents; hormone inhibitor |
| 05/26/2005 | WO2005009361A3 Method of treating hit patients with argatroban |
| 05/17/2005 | CA2057099C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 05/12/2005 | WO2005042422A2 Optical fiber with low pmd and method of making it by spinning |
| 05/12/2005 | US20050101583 Process and intermediates for the production of 7-substituted antiestrogens |
| 05/03/2005 | US6887991 Converting a 7-cyano substituted steroid to the corresponding 7- carboxylic acid substituted steroid, and thereafter converting the 7-carboxylic acid substituted steroid to the corresponding 5,7-lactone substituted steroid |
| 04/28/2005 | US20050090675 Oxidation with hydrogen peroxide in basic environment/polar solvent; crystallization; for producing fluticasone propionate |
| 04/28/2005 | US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom |
| 04/27/2005 | EP1526139A1 A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters |
| 04/26/2005 | CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 04/20/2005 | EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/14/2005 | US20050080065 corticosteroid with anti-inflammatory activity |
| 04/13/2005 | EP1522543A1 Use Steroid sulphatase inhibitors for the manufacture of a medicament for the treatment of an oestrogen dependent tumour |